Restricted accessResearch articleFirst published online 2014-07
Functional Comparison of Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Cells and Bone Marrow-Derived Mesenchymal Stromal Cells from the Same Donor
Mesenchymal stem cells (MSCs) have a high potential for therapeutic efficacy in treating diverse musculoskeletal injuries and cardiovascular diseases, and for ameliorating the severity of graft-versus-host and autoimmune diseases. While most of these clinical applications require substantial cell quantities, the number of MSCs that can be obtained initially from a single donor is limited. Reports on the derivation of MSC-like cells from pluripotent stem cells (PSCs) are, thus, of interest, as the infinite proliferative capacity of PSCs opens the possibility to generate large amounts of uniform batches of MSCs. However, characterization of such MSC-like cells is currently inadequate, especially with regard to the question of whether these cells are equivalent or identical to MSCs. In this study, we have derived MSC-like cells [induced PSC-derived MSC-like progenitor cells (iMPCs)] using four different methodologies from a newly established induced PSC line reprogrammed from human bone marrow stromal cells (BMSCs), and compared the iMPCs directly with the originating parental BMSCs. The iMPCs exhibited typical MSC/fibroblastic morphology and MSC-typical surface marker profile, and they were capable of differentiation in vitro along the osteogenic, chondrogenic, and adipogenic lineages. However, compared with the parental BMSCs, iMPCs displayed a unique expression pattern of mesenchymal and pluripotency genes and were less responsive to traditional BMSC differentiation protocols. We, therefore, conclude that iMPCs generated from PSCs via spontaneous differentiation represent a distinct population of cells which exhibit MSC-like characteristics.
Get full access to this article
View all access options for this article.
References
1.
CaplanAI and DennisJE. (2006). Mesenchymal stem cells as trophic mediators. J Cell Biochem, 98:1076–1084.
2.
NautaAJ and FibbeWE. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood, 110:3499–3506.
3.
BruderSP, JaiswalN and HaynesworthSE. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem, 64:278–294.
4.
StolzingA, JonesE, McGonagleD and ScuttA. (2008). Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev, 129:163–173.
5.
BiebackK and BrinkmannI. (2010). Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells, 2:81–92.
6.
GuillotPV, GotherstromC, ChanJ, KurataH and FiskNM. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells, 25:646–654.
7.
WuSM and HochedlingerK. (2011). Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol, 13:497–505.
8.
BarberiT, WillisLM, SocciND and StuderL. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med, 2:e161
9.
LianQ, LyeE, Suan YeoK, Khia Way TanE, Salto-TellezM, LiuTM, PalanisamyN, El OakleyRM, LeeEH, LimB and LimSK. (2007). Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells, 25:425–436.
10.
BarbetR, PeifferI, HatzfeldA, CharbordP and HatzfeldJA. (2011). Comparison of gene expression in human embryonic stem cells, hESC-derived mesenchymal stem cells and human mesenchymal stem cells. Stem Cells Int, 2011:368192
11.
LeeEJ, LeeHN, KangHJ, KimKH, HurJ, ChoHJ, LeeJ, ChungHM, ChoJ, et al. (2010). Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A, 16:705–715.
12.
KarlssonC, EmanuelssonK, WessbergF, KajicK, AxellMZ, ErikssonPS, LindahlA, HyllnerJ and StrehlR. (2009). Human embryonic stem cell-derived mesenchymal progenitors—potential in regenerative medicine. Stem Cell Res, 3:39–50.
13.
TrivediP and HemattiP. (2007). Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol, 35:146–154.
14.
HwangNS, VargheseS, LeeHJ, ZhangZ, YeZ, BaeJ, ChengL and ElisseeffJ. (2008). In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A, 105:20641–20646.
15.
de PeppoGM, SvenssonS, LennerasM, SynnergrenJ, StenbergJ, StrehlR, HyllnerJ, ThomsenP and KarlssonC. (2010). Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A, 16:2161–2182.
16.
OlivierEN and BouhassiraEE. (2011). Differentiation of human embryonic stem cells into mesenchymal stem cells by the “raclure”. method. Methods Mol Biol, 690:183–193.
17.
TrivediP and HemattiP. (2008). Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol, 36:350–359.
18.
PhinneyDG, KopenG, RighterW, WebsterS, TremainN and ProckopDJ. (1999). Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem, 75:424–436.
19.
Pevsner-FischerM, LevinS and ZiporiD. (2011). The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev, 7:560–568.
20.
DeyleDR, KhanIF, RenG, WangPR, KhoJ, SchwarzeU and RussellDW. (2012). Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Mol Ther, 20:204–213.
21.
KuznetsovSA, ChermanN and RobeyPG. (2011). In vivo bone formation by progeny of human embryonic stem cells. Stem Cells Dev, 20:269–287.
22.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
23.
BourinP, BunnellBA, CasteillaL, DominiciM, KatzAJ, MarchKL, RedlH, RubinJP, YoshimuraK and GimbleJM. (2013). Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics (IFATS) and Science and the International Society for Cellular Therapy (ISCT). Cytotherapy, 15:641–648.
24.
YagiH, TanJ and TuanRS. (2012). Polyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cells. J Cell Biochem, 114:1163–1173.
25.
CatersonEJ, NestiLJ, DanielsonKG and TuanRS. (2002). Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol, 20:245–256.
26.
LinB, KimJ, LiY, PanH, Carvajal-VergaraX, SalamaG, ChengT, LiY, LoCW and YangL. (2012). High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc Res, 95:327–335.
27.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
28.
MomcilovicO, KnoblochL, FornsaglioJ, VarumS, EasleyC and SchattenG. (2010). DNA damage responses in human induced pluripotent stem cells and embryonic stem cells. PLoS One, 5:e13410
29.
TeramuraT, OnoderaY, MiharaT, HosoiY, HamanishiC and FukudaK. (2010). Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cell Reprogram, 12:249–261.
30.
LinH, YangG, TanJ and TuanRS. (2012). Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials, 33:4480–4489.
31.
MaroltD, CamposIM, BhumiratanaS, KorenA, PetridisP, ZhangG, SpitalnikPF, GraysonWL and Vunjak-NovakovicG. (2012). Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A, 109:8705–8709.
32.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
33.
SanchezL, Gutierrez-ArandaI, LigeroG, RubioR, Munoz-LopezM, Garcia-PerezJL, RamosV, RealPJ, BuenoC, et al. (2011). Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells, 29:251–262.
34.
LianQ, ZhangY, ZhangJ, ZhangHK, WuX, LamFF, KangS, XiaJC, LaiWH, et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation, 121:1113–1123.
35.
OlivierEN, RybickiAC and BouhassiraEE. (2006). Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells, 24:1914–1922.
36.
DiederichsS, BaralK, TannerM and RichterW. (2012). Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng Part A, 18:1140–1150.
37.
JanickiP, BoeufS, SteckE, EgermannM, KastenP and RichterW. (2011). Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater, 21:488–507.
38.
EvansND, SwainRJ, GentlemanE, GentlemanMM and StevensMM. (2012). Gene-expression analysis reveals that embryonic stem cells cultured under osteogenic conditions produce mineral non-specifically compared to marrow stromal cells or osteoblasts. Eur Cell Mater, 24:211–223.
39.
ArpornmaeklongP, BrownSE, WangZ and KrebsbachPH. (2009). Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev, 18:955–968.
40.
YenML, HouCH, PengKY, TsengPC, JiangSS, ShunCT, ChenYC and KuoML. (2011). Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant, 20:1529–1545.
41.
DomevH, AmitM, LaevskyI, DarA and Itskovitz-EldorJ. (2012). Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells. Tissue Eng Part A, 18:2290–2302.
42.
ChenYS, PelekanosRA, EllisRL, HorneR, WolvetangEJ and FiskNM. (2012). Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med, 1:83–95.
43.
LeeEJ, KangHJ, LeeHN, KangSK, KimKH, LeeSW, LeeG, ParkYB and KimHS. (2012). New culture system for human embryonic stem cells: autologous mesenchymal stem cell feeder without exogenous fibroblast growth factor 2. Differentiation, 83:92–100.
44.
VargaN, VerebZ, RajnavolgyiE, NemetK, UherF, SarkadiB and ApatiA. (2011). Mesenchymal stem cell like (MSCl) cells generated from human embryonic stem cells support pluripotent cell growth. Biochem Biophys Res Commun, 414:474–480.
45.
Villa-DiazLG, BrownSE, LiuY, RossAM, LahannJ, ParentJM and KrebsbachPH. (2012). Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells, 30:1174–1181.
46.
BoxallSA and JonesE. (2012). Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int, 2012:975871
47.
FujitaH, YamamotoM, OginoT, KobuchiH, OhmotoN, AoyamaE, OkaT, NakanishiT, InoueK and SasakiJ. (2013). Necrotic and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro. Cell Biochem Funct, 32:77–86.
48.
NasuA, IkeyaM, YamamotoT, WatanabeA, JinY, MatsumotoY, HayakawaK, AmanoN, SatoS, et al. (2013). Genetically matched human iPS cells reveal that propensity for cartilage and bone differentiation differs with clones, not cell type of origin. PLoS One, 8:e53771
49.
YangSL, HarnishE, LeeuwT, DietzU, BatchelderE, WrightPS, PeppardJ, AugustP, Volle-ChallierC, et al. (2012). Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis. Protein Cell, 3:934–942.
50.
KattmanSJ, WittyAD, GagliardiM, DuboisNC, NiapourM, HottaA, EllisJ and KellerG. (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8:228–240.
51.
NostroMC, ChengX, KellerGM and GadueP. (2008). Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell, 2:60–71.
52.
KuhnLT, LiuY, BoydNL, DennisJ, JiangX, XinX, CharlesL, WangL, AguilaHL, et al. (2013). Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A, 20:365–377.
53.
SzeSK, de KleijnDP, LaiRC, Khia Way TanE, ZhaoH, YeoKS, LowTY, LianQ, LeeCN, et al. (2007). Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics, 6:1680–1689.
54.
EvseenkoD, ZhuY, Schenke-LaylandK, KuoJ, LatourB, GeS, ScholesJ, DravidG, LiX, MacLellanWR and CrooksGM. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A, 107:13742–13747.
55.
UmedaK, ZhaoJ, SimmonsP, StanleyE, ElefantyA and NakayamaN. (2012). Human chondrogenic paraxial mesoderm, directed specification and prospective isolation from pluripotent stem cells. Sci Rep, 2:455
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
